Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Xandra García-González"'
Autor:
Rosa Melero, Beatriz Torroba-Sanz, Marian Goicoechea, Iago Sousa-Casasnovas, Jose María Barrio, Ana María García-Prieto, Patrocinio Rodriguez-Benitez, Xandra García-González, María Sanjurjo-Sáez
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3329 (2024)
Cardiorenal syndrome (CRS) involves joint dysfunction of the heart and kidney. Acute forms share biochemical alterations like hyperuricaemia (HU) with tumour lysis syndrome (TLS). The mainstay treatment of acute CRS with systemic overload is diuretic
Externí odkaz:
https://doaj.org/article/99d40465ca144cf58fc7df35cf18a704
Autor:
Miguel Ángel Amor-García, Sara Ibáñez-García, Xandra García-González, Teresa Mombiela, Cristina Villanueva-Bueno, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Patients with pulmonary hypertension (PH) have progressive and disabling symptoms, as well as a burden of treatments and a difficult clinical evaluation that make health-related quality of life a particularly relevant endpoint in
Externí odkaz:
https://doaj.org/article/b8bf07f7ea6d44489603f2d4079c0311
Autor:
Xandra García-González, Esther Cubo, Lucía Simón-Vicente, Natividad Mariscal, Raquel Alcaraz, Laura Aguado, Jéssica Rivadeneyra-Posadas, Antonio Sanz-Solas, Miriam Saiz-Rodríguez
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 3, p 385 (2023)
Huntington’s disease (HD) is an autosomal dominant progressive brain disorder, caused by a pathological expansion of a CAG repeat that encodes the huntingtin gene. This genetic neurodegenerative rare disease is characterized by cognitive, motor, an
Externí odkaz:
https://doaj.org/article/21b2856593204a6fb6d08889f91d17df
Autor:
Juan Vicente-Valor, Xandra García-González, Sara Ibáñez-García, María Esther Durán-García, Ana de Lorenzo-Pinto, Carmen Rodríguez-González, Irene Méndez-Fernández, Juan Carlos Percovich-Hualpa, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 146, Iss , Pp 112519- (2022)
Introduction: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have emerged as a therapeutic option for patients with hypercholesterolemia who do not attain low-density lipoprotein cholesterol (LDL-C) goals and/or are intolerant to o
Externí odkaz:
https://doaj.org/article/6c2b7dc3df8241199afc135d4d687eab
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 11, p 1180 (2021)
Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant
Externí odkaz:
https://doaj.org/article/ee9c57be612740ca8986a2041b14ae6c
Autor:
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García-Alfonso, José Luis Revuelta-Herrero, Fabienne Thomas, Sara López-Tarruella, Xandra García-González, Aitana Calvo, Malika Yakoubi, Sara Salvador-Martín, Flora López-López, Iker Aguilar, María Sanjurjo-Sáez, Miguel Martín, Luis Andrés López-Fernández
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 8, p 792 (2021)
Dihydropyrimidine dehydrogenase deficiency is a major cause of severe fluoropyrimidine-induced toxicity and could lead to interruption of chemotherapy or life-threatening adverse reactions. This study aimed to characterize the DPYD exon sequence, mRN
Externí odkaz:
https://doaj.org/article/0fd983093d884816ae4c59febb4bf0b5
Autor:
Alicia Galar, Maricela Valerio, Pilar Catalán, Xandra García-González, Almudena Burillo, Ana Fernández-Cruz, Eduardo Zataráin, Iago Sousa-Casasnovas, Fernando Anaya, María Luisa Rodríguez-Ferrero, Patricia Muñoz, Emilio Bouza
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 77 (2021)
Valganciclovir (VGCV) and ganciclovir (GCV) doses must be adjusted according to indication, renal function and weight. No specific therapeutic exposure values have been established. We aimed to evaluate the adequacy of VGCV/GCV doses, to assess the i
Externí odkaz:
https://doaj.org/article/9a8f55dfdc634a09a553a8c36a2f8848
Autor:
Beatriz Torroba-Sanz, Ana de Lorenzo-Pinto, Almudena Ribed-Sánchez, María Luisa Martin-Barbero, Álvaro Giménez-Manzorro, Xandra García-González, Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Saez
Publikováno v:
Farmacia Hospitalaria. 47:T26-T30
Autor:
Beatriz Torroba-Sanz, Ana de Lorenzo-Pinto, Almudena Ribed-Sánchez, María Luisa Martin-Barbero, Álvaro Giménez-Manzorro, Xandra García-González, Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Saez
Publikováno v:
Farmacia Hospitalaria. 47:26-30
Autor:
Sara Ibáñez-García, Francisco Jesús Fernández-Avilés Díaz, Juan Fernández-Yáñez, Xandra García-González, Eduardo Zataraín-Nicolás, María Sanjurjo Sáez, Maria Luisa Rodríguez-Ferrero
Publikováno v:
International Journal of Clinical Pharmacy. 43:731-736
Background and objective The main objective was to evaluate the impact of Hepatitis C Virus treatment with direct-acting antiviral agents on tacrolimus blood levels in recipients of kidney and heart allografts. Method We analysed Hepatitis C Virus in